Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Denning

Showing results (151-160 of 466) with videos related to

Pageof 47
Sort By:
Journal of Fungi (Basel, Switzerland)|May 24, 2024
Mapping the Burden of Fungal Diseases in the United Arab EmiratesFatima Al Dhaheri, Jens Thomsen, Dean Everett, et al.
Journal of Fungi (Basel, Switzerland)|January 27, 2018
HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Rita O Oladele, Felix Bongomin, Sara Gago, et al.
Mycoses|March 18, 2020
Current burden of serious fungal infections in Republic of CongoFructueux M Amona, David W Denning, Donatien Moukassa, et al.
Infectious Diseases (London, England)|September 24, 2016
Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndromeChris Kosmidis, Pippa Newton, Eavan G Muldoon, et al.
Respirology (Carlton, Vic.)|November 14, 2009
The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosisAlessandro C Pasqualotto, Georgina Powell, Robert Niven, et al.
The Journal of Infection|July 5, 2016
Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosisPippa J Newton, Chris Harris, Julie Morris, et al.
The Journal of Antimicrobial Chemotherapy|July 28, 2005
Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalisPeter A Warn, Andrew Sharp, Graham Morrissey, et al.
The Lancet. Infectious Diseases|September 21, 2024
Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settingsRichard Kwizera, Alireza Abdolrasouli, Guillermo Garcia-Effron, et al.
Journal of Fungi (Basel, Switzerland)|March 22, 2018
Burden of Fungal Infections in ColombiaCarlos Arturo Alvarez-Moreno, Jorge Alberto Cortes, David W Denning
The Journal of Antimicrobial Chemotherapy|August 13, 2016
Global access to antifungal therapy and its variable costMatthew Kneale, Jennifer S Bartholomew, Emma Davies, et al.
Pageof 47

Showing results (151-160 of 466) with videos related to

Sort By:
Pageof 47
Journal of Fungi (Basel, Switzerland)|May 24, 2024
Mapping the Burden of Fungal Diseases in the United Arab EmiratesFatima Al Dhaheri, Jens Thomsen, Dean Everett, et al.
Journal of Fungi (Basel, Switzerland)|January 27, 2018
HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Rita O Oladele, Felix Bongomin, Sara Gago, et al.
Mycoses|March 18, 2020
Current burden of serious fungal infections in Republic of CongoFructueux M Amona, David W Denning, Donatien Moukassa, et al.
Infectious Diseases (London, England)|September 24, 2016
Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndromeChris Kosmidis, Pippa Newton, Eavan G Muldoon, et al.
Respirology (Carlton, Vic.)|November 14, 2009
The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosisAlessandro C Pasqualotto, Georgina Powell, Robert Niven, et al.
The Journal of Infection|July 5, 2016
Impact of liposomal amphotericin B therapy on chronic pulmonary aspergillosisPippa J Newton, Chris Harris, Julie Morris, et al.
The Journal of Antimicrobial Chemotherapy|July 28, 2005
Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalisPeter A Warn, Andrew Sharp, Graham Morrissey, et al.
The Lancet. Infectious Diseases|September 21, 2024
Antifungal susceptibility testing: applicability of methods and strategies for improving access in resource-constrained settingsRichard Kwizera, Alireza Abdolrasouli, Guillermo Garcia-Effron, et al.
Journal of Fungi (Basel, Switzerland)|March 22, 2018
Burden of Fungal Infections in ColombiaCarlos Arturo Alvarez-Moreno, Jorge Alberto Cortes, David W Denning
The Journal of Antimicrobial Chemotherapy|August 13, 2016
Global access to antifungal therapy and its variable costMatthew Kneale, Jennifer S Bartholomew, Emma Davies, et al.
Pageof 47